# Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP

> **NCT01540058** · PHASE3 · COMPLETED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 243 (actual)

## Conditions studied

- Neoplasms, Unknown Primary

## Interventions

- **OTHER:** Cancer Type ID test
- **OTHER:** No test Empiric strategy

## Key facts

- **NCT ID:** NCT01540058
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-22
- **Primary completion:** 2019-08-27
- **Final completion:** 2019-08-27
- **Target enrollment:** 243 (ACTUAL)
- **Last updated:** 2020-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01540058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01540058, "Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01540058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*